Found 57 results
Filters: Author is Butler, Tracy  [Clear All Filters]
2024
Mehta NH, Wang X, Keil SA, Xi K, Zhou L, Lee K, Tan W, Spector E, Goldan A, Kelly J et al..  2024.  [1-11C]-Butanol Positron Emission Tomography reveals an impaired brain to nasal turbinates pathway in aging amyloid positive subjects.. Fluids Barriers CNS. 21(1):30.
Kim RT, Zhou L, Li Y, Krieger AC, Nordvig AS, Butler T, de Leon MJ, Chiang GC.  2024.  Impaired sleep is associated with tau deposition on 18F-flortaucipir PET and accelerated cognitive decline, accounting for medications that affect sleep.. J Neurol Sci. 458:122927.
2023
Kim N, Jamison K, Jaywant A, Garetti J, Blunt E, RoyChoudhury A, Butler T, Dams-O'Connor K, Khedr S, Chen C-C et al..  2023.  Comparisons of electrophysiological markers of impaired executive attention after traumatic brain injury and in healthy aging.. Neuroimage. 274:120126.
Butler T.  2023.  Environmental toxins in breast milk and risk of early onset colorectal cancer.. Clin Gastroenterol Hepatol.
Butler T, Zhou L, Ozsahin I, Wang XHugh, Garetti J, Zetterberg H, Blennow K, Jamison K, de Leon MJ, Li Y et al..  2023.  Glymphatic clearance estimated using diffusion tensor imaging along perivascular spaces is reduced after traumatic brain injury and correlates with plasma neurofilament light, a biomarker of injury severity.. Brain Commun. 5(3):fcad134.
Butler T.  2023.  Letter to the Editor: Intense Exercise and Associated Blood-Brain Barrier Leakiness and Systemic Inflammation at the Time of Brain Injury May Be Relevant to Understanding Why Only Sports-Related Concussions Are Assoc. W/ Chronic Traumatic Encephalopathy.. J Neurotrauma. 40(11-12):1255-1256.
Mehta NH, Zhou L, Li Y, McIntire LBeth, Nordvig A, Butler T, de Leon M, Chiang GC.  2023.  Peripheral immune cell imbalance is associated with cortical beta-amyloid deposition and longitudinal cognitive decline.. Sci Rep. 13(1):8847.
2022
Li Y, Rusinek H, Butler T, Glodzik L, Pirraglia E, Babich J, P Mozley D, Nehmeh S, Pahlajani S, Wang X et al..  2022.  Decreased CSF clearance and increased brain amyloid in Alzheimer's disease.. Fluids Barriers CNS. 19(1):21.
Butler T, Chiang GC, Niogi SNarayan, Wang XHugh, Skudin C, Tanzi E, Wickramasuriya N, Spiegel J, Maloney T, Pahlajani S et al..  2022.  Tau PET following acute TBI: Off-target binding to blood products, tauopathy, or both? Front Neuroimaging. 1
2021
Mehta NH, Sherbansky J, Kamer AR, Carare RO, Butler T, Rusinek H, Chiang GC, Li Y, Strauss S, Saint-Louis LA et al..  2021.  The Brain-Nose Interface: A Potential Cerebrospinal Fluid Clearance Site in Humans.. Front Physiol. 12:769948.
Weisholtz DS, Kreiman G, Silbersweig DA, Stern E, Cha B, Butler T.  2021.  Localized Task-Invariant Emotional Valence Encoding Revealed by Intracranial Recordings.. Soc Cogn Affect Neurosci.
Kamer AR, Pushalkar S, Gulivindala D, Butler T, Li Y, Annam KRaghava Ch, Glodzik L, Ballman KV, Corby PM, Blennow K et al..  2021.  Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly.. Alzheimers Dement (Amst). 13(1):e12172.
Butler T, Goldberg JD, Galvin JE, Maloney T, Ravdin L, Glodzik L, de Leon MJ, Hochman T, Bowen RL, Atwood CS.  2021.  Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.. Contemp Clin Trials. 107:106488.
2019
Glodzik L, Rusinek H, Tsui W, Pirraglia E, Kim H-J, Deshpande A, Li Y, Storey P, Randall C, Chen J et al..  2019.  Different Relationship Between Systolic Blood Pressure and Cerebral Perfusion in Subjects With and Without Hypertension.. Hypertension. 73(1):197-205.
Butler T, Harvey P, Cardozo L, Zhu Y-S, Mosa A, Tanzi E, Pervez F.  2019.  Epilepsy, depression, and growth hormone.. Epilepsy Behav. 94:297-300.
Fossati S, Cejudo JRamos, Debure L, Pirraglia E, Sone JYeong, Li Y, Chen J, Butler T, Zetterberg H, Blennow K et al..  2019.  Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease.. Alzheimers Dement (Amst). 11:483-492.
Butler T, Deshpande A, Harvey P, Li Y, Rusinek H, Pirraglia E, Osorio RS, Glodzik L, de Leon MJ, Madelin G et al..  2019.  Precisely-Measured Hydration Status Correlates with Hippocampal Volume in Healthy Older Adults.. Am J Geriatr Psychiatry. 27(6):653-654.
Butler T, Bowen R, Atwood CS.  2019.  Septal hypertrophy and cell cycle re-entry in AD.. Aging (Albany NY). 11(2):297-298.
2018
Butler T, Harvey P, Deshpande A, Tanzi E, Li Y, Tsui W, Silver C, Fischer E, Wang X, Chen J et al..  2018.  Basal forebrain septal nuclei are enlarged in healthy subjects prior to the development of Alzheimer's disease.. Neurobiol Aging. 65:201-205.
de Leon MJ, Pirraglia E, Osorio RS, Glodzik L, Saint-Louis L, Kim H-J, Fortea J, Fossati S, Laska E, Siegel C et al..  2018.  The nonlinear relationship between cerebrospinal fluid Aβ42 and tau in preclinical Alzheimer's disease.. PLoS One. 13(2):e0191240.
Sharma RA, Varga AW, Bubu OM, Pirraglia E, Kam K, Parekh A, Wohlleber M, Miller MD, Andrade A, Lewis C et al..  2018.  Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study.. Am J Respir Crit Care Med. 197(7):933-943.
2017
de Leon MJ, Li Y, Okamura N, Tsui WH, Saint-Louis LA, Glodzik L, Osorio RS, Fortea J, Butler T, Pirraglia E et al..  2017.  Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET.. J Nucl Med. 58(9):1471-1476.
2016
Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV et al..  2016.  Clearance systems in the brain--implications for Alzheimer diseaser.. Nat Rev Neurol. 12(4):248.
Glodzik L, Rusinek H, Kamer A, Pirraglia E, Tsui W, Mosconi L, Li Y, McHugh P, Murray J, Williams S et al..  2016.  Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects.. Alzheimers Dement (Amst). 2:95-104.
Spiegel J, Pirraglia E, Osorio RS, Glodzik L, Li Y, Tsui W, Louis LASaint, Randall C, Butler T, Xu J et al..  2016.  Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.. J Alzheimers Dis. 49(1):93-100.